Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Mesalamine 36 and multiple sclerosis (MS)-CU analog 37 Over the past several years, extensive studies have been conducted to develop COX-2 inhibitors using tetracyclic main scaffolds
Patient-specific redox profiling may guide personalized treatment selection while hybrid multifunctional nanoplatforms integrating therapy, imaging, and GSH modulation can enhance therapeutic precision
Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G et al (2009) Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control
Nitta, A., Imai, S., Kajiyama, S., Miyawaki, T., Matsumoto, S., Ozasa, N., et al
US$ 25.05
US$ 29.52
US$ 21.98
US$ 28.66
